Higher Tax Margin Rate Disappoints Pfizer’s Investors
‘New tax rate’ of Pfizer exceeds investors’ expectations and pulls down its shares.
Drug
Pfizer & Merck’s Joint Venture In Diabetes Drug Gets EMA Committee’s Recommendation
Steglatro will be treating type II diabetes orally.
AstraZeneca’s Durvalumab Treatment Receives Fast-Track Approval
The most of promising cancer drug developed by AstraZeneca, will speed up its research under FDA’s guidance.
Links Between Antidepressants & Birth Defect Risks Become Clearer
The latest study shows that the usage of Paxil or Prozac by a woman during her conception can lead to a birth defect in her baby.
